Luis B. Agellon

12.0k total citations · 4 hit papers
150 papers, 9.4k citations indexed

About

Luis B. Agellon is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Luis B. Agellon has authored 150 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 49 papers in Surgery and 38 papers in Oncology. Recurrent topics in Luis B. Agellon's work include Drug Transport and Resistance Mechanisms (36 papers), Cholesterol and Lipid Metabolism (32 papers) and Peroxisome Proliferator-Activated Receptors (27 papers). Luis B. Agellon is often cited by papers focused on Drug Transport and Resistance Mechanisms (36 papers), Cholesterol and Lipid Metabolism (32 papers) and Peroxisome Proliferator-Activated Receptors (27 papers). Luis B. Agellon collaborates with scholars based in Canada, United States and Netherlands. Luis B. Agellon's co-authors include Marek Michalak, Alan R. Tall, Dennis E. Vance, Salam M. Habib, Jianguo Xia, Jasmine Chong, Achal Dhariwal, Irah L. King, Jody Groenendyk and Joachim Krebs and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Luis B. Agellon

149 papers receiving 9.2k citations

Hit Papers

MicrobiomeAnalyst: a... 1990 2026 2002 2014 2017 1990 2006 2015 400 800 1.2k

Peers

Luis B. Agellon
Jeffrey G. McDonald United States
Beverly Paigen United States
William S. Blaner United States
Robert Kleemann Netherlands
Yu Li China
Jeffrey G. McDonald United States
Luis B. Agellon
Citations per year, relative to Luis B. Agellon Luis B. Agellon (= 1×) peers Jeffrey G. McDonald

Countries citing papers authored by Luis B. Agellon

Since Specialization
Citations

This map shows the geographic impact of Luis B. Agellon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis B. Agellon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis B. Agellon more than expected).

Fields of papers citing papers by Luis B. Agellon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis B. Agellon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis B. Agellon. The network helps show where Luis B. Agellon may publish in the future.

Co-authorship network of co-authors of Luis B. Agellon

This figure shows the co-authorship network connecting the top 25 collaborators of Luis B. Agellon. A scholar is included among the top collaborators of Luis B. Agellon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis B. Agellon. Luis B. Agellon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avizonis, Daina, et al.. (2024). Ablating the glutaredoxin-2 (Glrx2) gene protects male mice against non-alcoholic fatty liver disease (NAFLD) by limiting oxidative distress. Free Radical Biology and Medicine. 224. 660–677. 4 indexed citations
2.
Eggleton, Paul, Alex S. Ferecskó, Nick Gutowski, et al.. (2024). Endothelial Cell-Derived Soluble CD200 Determines the Ability of Immune Cells to Cross the Blood–Brain Barrier. International Journal of Molecular Sciences. 25(17). 9262–9262. 1 indexed citations
3.
Michalak, Marek, et al.. (2023). Calnexin, More Than Just a Molecular Chaperone. Cells. 12(3). 403–403. 30 indexed citations
4.
Agellon, Luis B.. (2023). Importance of fatty acid binding proteins in cellular function and organismal metabolism. Journal of Cellular and Molecular Medicine. 28(5). e17703–e17703. 10 indexed citations
5.
Gutierrez, Karina, Werner Giehl Glanzner, Naomi Dicks, et al.. (2022). Cell Cycle Stage and DNA Repair Pathway Influence CRISPR/Cas9 Gene Editing Efficiency in Porcine Embryos. Life. 12(2). 171–171. 2 indexed citations
6.
Michalak, Marek & Luis B. Agellon. (2018). Stress Coping Strategies in the Heart: An Integrated View. Frontiers in Cardiovascular Medicine. 5. 168–168. 15 indexed citations
7.
Charonis, Aristidis, Marek Michalak, Jody Groenendyk, & Luis B. Agellon. (2017). Endoplasmic reticulum in health and disease: the 12th International Calreticulin Workshop, Delphi, Greece. Journal of Cellular and Molecular Medicine. 21(12). 3141–3149. 13 indexed citations
8.
Li, Zhaoyu, Luis B. Agellon, & Dennis E. Vance. (2007). Choline Redistribution during Adaptation to Choline Deprivation. Journal of Biological Chemistry. 282(14). 10283–10289. 40 indexed citations
9.
Verkade, Henkjan J., Rick Havinga, David J. Shields, et al.. (2007). The phosphatidylethanolamine N-methyltransferase pathway is quantitatively not essential for biliary phosphatidylcholine secretion. Journal of Lipid Research. 48(9). 2058–2064. 15 indexed citations
10.
Li, Zhaoyu, Luis B. Agellon, Theresa M. Allen, et al.. (2006). The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metabolism. 3(5). 321–331. 576 indexed citations breakdown →
11.
Bijvelds, Marcel J. C., Huub Jorna, Henkjan J. Verkade, et al.. (2005). Activation of CFTR by ASBT-mediated bile salt absorption. American Journal of Physiology-Gastrointestinal and Liver Physiology. 289(5). G870–G879. 27 indexed citations
12.
Sahoo, Daisy, Teddy Chan, Victor A. Drover, et al.. (2004). ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes. Journal of Lipid Research. 45(6). 1122–1131. 80 indexed citations
13.
Elzinga, Baukje M., Julius F.W. Baller, Arjen R. Mensenkamp, et al.. (2003). Inhibition of apolipoprotein B secretion by taurocholate is controlled by the N-terminal end of the protein in rat hepatoma McArdle-RH7777 cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1635(2-3). 93–103. 5 indexed citations
14.
Shields, David J., Richard Lehner, Luis B. Agellon, & Dennis E. Vance. (2003). Membrane Topography of Human Phosphatidylethanolamine N-Methyltransferase. Journal of Biological Chemistry. 278(5). 2956–2962. 38 indexed citations
15.
Guo, Lei, Jeffrey M. Lynch, Kimitoshi Nakamura, et al.. (2001). COUP-TF1 Antagonizes Nkx2.5-mediated Activation of the Calreticulin Gene during Cardiac Development. Journal of Biological Chemistry. 276(4). 2797–2801. 45 indexed citations
16.
Agellon, Luis B. & Enrique C. Torchia. (2000). Intracellular transport of bile acids. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1486(1). 198–209. 56 indexed citations
17.
Labonté, Eric D., Qianqian Li, & Luis B. Agellon. (2000). Expression of Cholesterol 7α-Hydroxylase Restores Bile Acid Synthesis in McArdle RH7777 Cells. Archives of Biochemistry and Biophysics. 381(2). 273–277. 5 indexed citations
19.
Wang, Suke, Liping Deng, Maryanne L. Brown, Luis B. Agellon, & Alan R. Tall. (1991). Structure-function studies of human cholesteryl ester transfer protein by linker insertion scanning mutagenesis. Biochemistry. 30(14). 3484–3490. 30 indexed citations
20.
Agellon, Luis B. & Thomas T. Chen. (1986). Rainbow Trout Growth Hormone: Molecular Cloning of cDNA and Expression in Escherichia coli. DNA. 5(6). 463–471. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026